Emmerich Ilka Ute
Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.
Tierarztl Prax Ausg G Grosstiere Nutztiere. 2023 Apr;51(2):93-96. doi: 10.1055/a-2062-7397. Epub 2023 May 25.
In 2022, one novel pharmaceutical agent was released on the German market for horses or food-producing animals: An injection suspension for horses containing tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells as the active ingredient (RenuTend) is now available. The authorization of one established veterinary active ingredient was extended to an additional species: The synthetic prostaglandin F-analogue cloprostenol (Syncroprost) received approval for goats. Additionally, for 2 active ingredients (paracetamol, suxibuzone), drugs with a higher content of the active ingredient were launched on the market for horses and food-producing animals.
2022年，一种新型药物制剂在德国马匹或食用动物市场上市：一种用于马匹的注射用混悬液现已上市，其活性成分是促腱分化的马异体外周血间充质干细胞（RenuTend）。一种已有的兽用活性成分的适用物种范围扩大到了另一个物种：合成前列腺素F类似物氯前列醇（Syncroprost）获批用于山羊。此外，对于两种活性成分（对乙酰氨基酚、舒布宗），活性成分含量更高的药物在马匹和食用动物市场上市。
